Atheana M Meadows, MA, CCC-A in Maysville, KY - Audiologist

Atheana M Meadows, MA, CCC-A is a Audiologist based in Maysville, Kentucky. Atheana M Meadows is licensed to practice in * (Not Available) (license number ) and her current practice location is 991 Medical Park Dr, Suite 301, Maysville, Kentucky. She can be reached at her office (for appointments etc.) via phone at (606) 759-4852.

NPI number for Atheana M Meadows is 1558535153 and her current mailing address is 491 Tucker Dr, Maysville, Kentucky. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1558535153.

Contact Information

	Atheana M Meadows, MA, CCC-A
	991 Medical Park Dr, Suite 301, Maysville, KY 41056-8764
	(606) 759-4852
	(606) 759-0122

Healthcare Provider's Profile

Full Name	Atheana M Meadows
Gender	Female
Speciality	Audiologist
Location	991 Medical Park Dr, Maysville, Kentucky
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1558535153
Provider Enumeration Date: 04/15/2008
Last Update Date: 09/19/2013

Medical Identifiers

Medical identifiers for Atheana M Meadows such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558535153	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	(* (Not Available))	Primary
237700000X	Hearing Instrument Specialist	(* (Not Available))	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Atheana M Meadows is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Atheana M Meadows, MA, CCC-A 491 Tucker Dr, Maysville, KY 41056-9111 Ph: (606) 759-4852	Atheana M Meadows, MA, CCC-A 991 Medical Park Dr, Suite 301, Maysville, KY 41056-8764 Ph: (606) 759-4852

News Archive

Rexahn submits Phase IIb protocol to FDA for study of Serdaxin for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.

Eisai announces results of perampanel Phase III study on epilepsy

Results presented today of a Phase III pivotal study for the investigational compound perampanel for partial-onset seizures showed that perampanel, 8 mg and 12 mg, produced statistically significant reductions in median seizure frequency compared to placebo among patients having partial-onset seizures while receiving treatment with one to three other epilepsy drugs.

Experimental sleep drug eszopiclone helps elderly to sleep better

Older people with insomnia slept better and longer after taking an experimental sleep medication, according to research at Wake Forest University Baptist Medical Center.

New study provides insight into mechanism behind breast cancer mutation

A new study sheds light on why individuals who inherit a particular family of mutations have a high risk of developing a very aggressive form of breast cancer. The research, published by Cell Press on February 4th in the journal Cell Stem Cell, shows that breast tissue cells from these individuals make abnormal cell-fate decisions even before cancer develops and provides exciting new insights into the mechanisms behind one of the most lethal types of breast cancer.

Atheana M Meadows, MA, CCC-A - Audiologist in Maysville, KY